| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 5.72e-06 | 12 | 212 | 4 | GO:0004706 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SPEG PAK4 LRRK2 OBSCN CDC7 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN LTBP1 PRKDC MAP3K13 MAP3K21 | 8.92e-05 | 446 | 212 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | SPEG PAK4 LRRK2 OBSCN CDC7 SIK2 MAP3K9 WNK2 TLK2 HASPIN PRKDC MAP3K13 MAP3K21 | 1.43e-04 | 363 | 212 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.79e-04 | 27 | 212 | 4 | GO:0004709 | |
| GeneOntologyMolecularFunction | protein kinase activity | SPEG PAK4 LRRK2 OBSCN CDC7 NRP1 JAK1 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN LTBP1 PRKDC MAP3K13 MAP3K21 | 2.40e-04 | 600 | 212 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | cytokine binding | 2.80e-04 | 157 | 212 | 8 | GO:0019955 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SPEG PAK4 LRRK2 OBSCN CDC7 NRP1 JAK1 CAMKV SIK2 MAP3K9 CLP1 GMPPB WNK2 TLK2 POLR3A NMNAT3 RPAP1 HASPIN LTBP1 PRKDC MAP3K13 MAP3K21 | 4.30e-04 | 938 | 212 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SPEG PAK4 LRRK2 OBSCN CDC7 NRP1 JAK1 CAMKV SIK2 MAP3K9 CLP1 WNK2 TLK2 HASPIN LTBP1 PRKDC MAP3K13 MAP3K21 | 5.87e-04 | 709 | 212 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 6.64e-04 | 4 | 212 | 2 | GO:0001642 | |
| Domain | EGF_Ca-bd_CS | 1.41e-06 | 97 | 209 | 9 | IPR018097 | |
| Domain | EGF_CA | 1.68e-06 | 99 | 209 | 9 | PS01187 | |
| Domain | EGF_CA | 9.48e-06 | 122 | 209 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.08e-05 | 124 | 209 | 9 | IPR001881 | |
| Domain | EGF_3 | MASP1 PTGS2 SVEP1 BMP1 HMCN2 ATRN THBS4 SLIT1 SLIT3 LTBP1 LTBP3 MEGF10 | 1.41e-05 | 235 | 209 | 12 | PS50026 |
| Domain | EGF-like_dom | MASP1 PTGS2 SVEP1 BMP1 HMCN2 ATRN THBS4 SLIT1 SLIT3 LTBP1 LTBP3 MEGF10 | 2.51e-05 | 249 | 209 | 12 | IPR000742 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.54e-05 | 106 | 209 | 8 | IPR000152 | |
| Domain | EGF_1 | MASP1 PTGS2 SVEP1 BMP1 HMCN2 ATRN THBS4 SLIT1 SLIT3 LTBP1 LTBP3 MEGF10 | 3.17e-05 | 255 | 209 | 12 | PS00022 |
| Domain | EGF-like_CS | MASP1 PTGS2 SVEP1 BMP1 HMCN2 ATRN THBS4 SLIT1 SLIT3 LTBP1 LTBP3 MEGF10 | 3.97e-05 | 261 | 209 | 12 | IPR013032 |
| Domain | EGF_2 | MASP1 PTGS2 SVEP1 BMP1 HMCN2 ATRN THBS4 SLIT1 SLIT3 LTBP1 LTBP3 MEGF10 | 4.61e-05 | 265 | 209 | 12 | PS01186 |
| Domain | EGF_CA | 5.05e-05 | 86 | 209 | 7 | PF07645 | |
| Domain | Ig_I-set | 5.74e-05 | 190 | 209 | 10 | IPR013098 | |
| Domain | I-set | 5.74e-05 | 190 | 209 | 10 | PF07679 | |
| Domain | Growth_fac_rcpt_ | 6.68e-05 | 156 | 209 | 9 | IPR009030 | |
| Domain | IGc2 | SPEG OBSCN LRFN2 HMCN2 MYPN CDON SEMA4D MXRA5 OBSL1 LINGO4 IGSF1 | 7.11e-05 | 235 | 209 | 11 | SM00408 |
| Domain | Ig_sub2 | SPEG OBSCN LRFN2 HMCN2 MYPN CDON SEMA4D MXRA5 OBSL1 LINGO4 IGSF1 | 7.11e-05 | 235 | 209 | 11 | IPR003598 |
| Domain | FN3 | 8.46e-05 | 199 | 209 | 10 | PS50853 | |
| Domain | EGF | 8.73e-05 | 126 | 209 | 8 | PF00008 | |
| Domain | FN3_dom | 1.27e-04 | 209 | 209 | 10 | IPR003961 | |
| Domain | Ig-like_fold | IL13RA1 MYCBP2 SPEG OBSCN IL20RA UNC5A LRFN2 HMCN2 MYPN CDON MPL SEMA4D IL31RA MXRA5 OBSL1 PTPRU IGHA1 IGHD LINGO4 IGSF1 | 1.36e-04 | 706 | 209 | 20 | IPR013783 |
| Domain | S_TKc | SPEG PAK4 LRRK2 OBSCN CDC7 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 MAP3K21 | 2.13e-04 | 359 | 209 | 13 | SM00220 |
| Domain | hEGF | 2.53e-04 | 28 | 209 | 4 | PF12661 | |
| Domain | EGF | 3.27e-04 | 235 | 209 | 10 | SM00181 | |
| Domain | Kinase-like_dom | SPEG PAK4 LRRK2 OBSCN CDC7 JAK1 ACAD11 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN PRKDC MAP3K13 MAP3K21 | 4.13e-04 | 542 | 209 | 16 | IPR011009 |
| Domain | IG_LIKE | SPEG OBSCN UNC5A LRFN2 HMCN2 MYPN CDON SEMA4D MXRA5 OBSL1 PTPRU IGHA1 IGHD LINGO4 IGSF1 | 4.38e-04 | 491 | 209 | 15 | PS50835 |
| Domain | fn3 | 4.87e-04 | 162 | 209 | 8 | PF00041 | |
| Domain | Ig-like_dom | SPEG OBSCN UNC5A LRFN2 HMCN2 MYPN CDON SEMA4D MXRA5 OBSL1 PTPRU IGHA1 IGHD LINGO4 IGSF1 | 5.63e-04 | 503 | 209 | 15 | IPR007110 |
| Domain | - | 6.95e-04 | 95 | 209 | 6 | 2.60.120.200 | |
| Domain | Ser/Thr_kinase_AS | SPEG PAK4 LRRK2 OBSCN CDC7 SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 MAP3K21 | 7.19e-04 | 357 | 209 | 12 | IPR008271 |
| Domain | MLK1/MLK2/MLK4 | 7.37e-04 | 4 | 209 | 2 | IPR016231 | |
| Domain | KCL_cotranspt | 7.37e-04 | 4 | 209 | 2 | IPR000076 | |
| Domain | MAP3K10 | 7.37e-04 | 4 | 209 | 2 | IPR015785 | |
| Domain | PROTEIN_KINASE_ST | SPEG PAK4 LRRK2 OBSCN CDC7 SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 MAP3K21 | 8.11e-04 | 362 | 209 | 12 | PS00108 |
| Domain | ConA-like_dom | 8.29e-04 | 219 | 209 | 9 | IPR013320 | |
| Domain | ASX_HYDROXYL | 9.10e-04 | 100 | 209 | 6 | PS00010 | |
| Domain | IG | SPEG OBSCN UNC5A LRFN2 HMCN2 MYPN CDON SEMA4D MXRA5 OBSL1 PTPRU LINGO4 IGSF1 | 9.53e-04 | 421 | 209 | 13 | SM00409 |
| Domain | Ig_sub | SPEG OBSCN UNC5A LRFN2 HMCN2 MYPN CDON SEMA4D MXRA5 OBSL1 PTPRU LINGO4 IGSF1 | 9.53e-04 | 421 | 209 | 13 | IPR003599 |
| Domain | FN3 | 1.16e-03 | 185 | 209 | 8 | SM00060 | |
| Domain | FYrich_C | 1.22e-03 | 5 | 209 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.22e-03 | 5 | 209 | 2 | IPR003888 | |
| Domain | FYRC | 1.22e-03 | 5 | 209 | 2 | SM00542 | |
| Domain | FYRN | 1.22e-03 | 5 | 209 | 2 | SM00541 | |
| Domain | UMA | 1.22e-03 | 5 | 209 | 2 | PS51497 | |
| Domain | UMA | 1.22e-03 | 5 | 209 | 2 | IPR023340 | |
| Domain | Tet-R_TetA/multi-R_MdtG | 1.22e-03 | 5 | 209 | 2 | IPR001958 | |
| Domain | DUF4704 | 1.22e-03 | 5 | 209 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.22e-03 | 5 | 209 | 2 | PF15787 | |
| Domain | FYRN | 1.22e-03 | 5 | 209 | 2 | PF05964 | |
| Domain | FYRC | 1.22e-03 | 5 | 209 | 2 | PF05965 | |
| Domain | FYRC | 1.22e-03 | 5 | 209 | 2 | PS51543 | |
| Domain | FYRN | 1.22e-03 | 5 | 209 | 2 | PS51542 | |
| Domain | Pkinase | SPEG PAK4 LRRK2 OBSCN CDC7 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 | 1.26e-03 | 381 | 209 | 12 | PF00069 |
| Domain | Prot_kinase_dom | SPEG PAK4 LRRK2 OBSCN CDC7 JAK1 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 MAP3K21 | 1.26e-03 | 489 | 209 | 14 | IPR000719 |
| Domain | - | IL13RA1 MYCBP2 SPEG OBSCN IL20RA UNC5A LRFN2 MYPN CDON MPL SEMA4D IL31RA MXRA5 OBSL1 PTPRU LINGO4 IGSF1 | 1.31e-03 | 663 | 209 | 17 | 2.60.40.10 |
| Domain | PROTEIN_KINASE_DOM | SPEG PAK4 LRRK2 OBSCN CDC7 JAK1 CAMKV SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 MAP3K21 | 1.36e-03 | 493 | 209 | 14 | PS50011 |
| Domain | UBA | 1.46e-03 | 44 | 209 | 4 | IPR015940 | |
| Domain | PH_BEACH | 1.81e-03 | 6 | 209 | 2 | PF14844 | |
| Domain | AA-permease/SLC12A_dom | 1.82e-03 | 22 | 209 | 3 | IPR004841 | |
| Domain | AA_permease | 1.82e-03 | 22 | 209 | 3 | PF00324 | |
| Domain | UBA | 1.87e-03 | 47 | 209 | 4 | PS50030 | |
| Domain | PROTEIN_KINASE_ATP | SPEG PAK4 LRRK2 OBSCN CDC7 JAK1 SIK2 MAP3K9 WNK2 TLK2 HASPIN MAP3K13 MAP3K21 | 2.06e-03 | 459 | 209 | 13 | PS00107 |
| Domain | CUB | 2.18e-03 | 49 | 209 | 4 | PF00431 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OBSCN ARHGEF17 TTLL12 KMT2C TDRD3 ZBED4 RECQL4 MAP3K9 NXF1 ATRN MXRA5 KIF26B RNF213 NBEA THBS4 RPAP1 TLN1 CHRD CEP295 PRKDC CFAP44 MEGF10 | 1.67e-09 | 736 | 217 | 22 | 29676528 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 MYCBP2 SPEG OBSCN AHDC1 ELAC2 KMT2C TDRD3 ZBED4 NBEAL2 WDR90 GCN1 WNK2 BAHCC1 TRAF7 SZT2 GRIN2D FAAP100 HIVEP3 KMT2D RPAP1 TLN1 SLC7A5 LTBP3 PRKDC MBD5 PRDM16 | 1.71e-09 | 1105 | 217 | 27 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 MYCBP2 MBD1 PAK4 MPDZ ARHGEF17 TTLL12 STARD9 SVIL SIK2 MAP3K9 KIF26B CRTC1 PLEKHG2 VPS13D IPO9 SLF2 LMO7 DOCK7 SKA3 MAP3K21 CDC25C AKAP1 | 5.81e-09 | 861 | 217 | 23 | 36931259 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | GBF1 MYCBP2 ATAD5 PAK4 TDRD3 RBMS3 MKI67 GCN1 NXF1 TLK2 DHX37 RBMS2 CHMP5 NIBAN2 PAF1 AKAP12 FAM193A LMO7 TLN1 DOCK7 PRR11 | 6.74e-09 | 724 | 217 | 21 | 36232890 |
| Pubmed | SPEG TSC1 ARHGEF17 SLC12A5 UNC5A LRFN2 ZBED4 STARD9 KATNIP OBSL1 VAT1L RPAP1 TLN1 SLIT1 DOCK7 PDZD2 | 7.13e-09 | 407 | 217 | 16 | 12693553 | |
| Pubmed | MYCBP2 ATAD5 PAK4 TSC1 PTEN BCOR TDRD3 SVIL NUP210 MKI67 GCN1 KNL1 KPNA1 PMPCB DUSP4 RNF213 NBEA NIBAN2 PTPRU PAF1 KMT2D IPO9 LTBP1 SLC12A7 CDC25C | 1.18e-08 | 1049 | 217 | 25 | 27880917 | |
| Pubmed | 1.54e-08 | 101 | 217 | 9 | 10997877 | ||
| Pubmed | LPCAT1 ATAD5 ATXN7L1 MBD1 BCL7B DCAF16 BCOR SQOR JAK1 HMCN2 ACAD11 KNL1 KPNA1 BAHCC1 TRAF7 ADAMTS1 PHRF1 OBSL1 RNF213 SIPA1 RFC4 ARHGAP4 ARID2 CEP295 PRDM16 | 3.91e-08 | 1116 | 217 | 25 | 31753913 | |
| Pubmed | NRIP1 MYCBP2 BCOR CLP1 GCN1 NXF1 CSTPP1 KNL1 CRTC1 POU5F1 KMT2D FAM193A DOCK7 SKA3 AKAP1 | 7.04e-08 | 418 | 217 | 15 | 34709266 | |
| Pubmed | 1.39e-07 | 130 | 217 | 9 | 12421765 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 TP53INP1 MYCBP2 SLC38A9 ATXN7L1 OBSCN PTEN AHDC1 TASOR2 NRP1 KMT2C LRFN2 NUP210 KATNIP VAV2 WNK2 KPNA1 ATRN SEMA4D C11orf54 ZNF875 CHMP5 RNF213 IQCN HIVEP3 MBD5 CATSPERG PDZD2 | 2.15e-07 | 1489 | 217 | 28 | 28611215 |
| Pubmed | KDM3A PAK4 SPCS2 BCOR KMT2C NBEAL2 WDR90 WNK2 NYAP2 SZT2 PHRF1 CRTC1 ARHGAP4 LMO7 SLIT3 IGSF1 | 2.60e-07 | 529 | 217 | 16 | 14621295 | |
| Pubmed | KCNH6 KMT2C MVB12A STARD9 NYNRIN MKI67 WNK2 TLK2 AKAP12 XIRP2 CEP295 | 2.80e-07 | 233 | 217 | 11 | 37704626 | |
| Pubmed | NRIP1 LPCAT1 ATAD5 RPL13AP3 BCOR ACAD11 KNL1 KPNA1 TCAF2 MXRA5 NYAP2 NBEA ZNF251 KMT2D IPO9 ARID2 CEP295 | 6.37e-07 | 638 | 217 | 17 | 31182584 | |
| Pubmed | Akt and mTORC1 have different roles during liver tumorigenesis in mice. | 9.54e-07 | 4 | 217 | 3 | 23376645 | |
| Pubmed | 1.69e-06 | 225 | 217 | 10 | 12168954 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATAD5 PAK4 TSC1 BCOR TDRD3 MKI67 PRR14L GCN1 CSTPP1 KNL1 NIBAN2 PAF1 RFC4 AKAP12 FAM193A ARID2 TLN1 PRKDC SKA3 AKAP1 | 1.92e-06 | 934 | 217 | 20 | 33916271 |
| Pubmed | Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles. | 2.37e-06 | 5 | 217 | 3 | 19843540 | |
| Pubmed | GBF1 SPCS2 TSC1 PRR14L GCN1 CSTPP1 CHMP5 NIBAN2 AKAP12 VPS13D TLN1 MOB3B SLC7A5 SLC12A7 AKAP1 | 3.30e-06 | 568 | 217 | 15 | 37774976 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 3.83e-06 | 38 | 217 | 5 | 11756498 | |
| Pubmed | 3.99e-06 | 103 | 217 | 7 | 10819331 | ||
| Pubmed | PDCD2 GBF1 PAK4 MPDZ ACAD11 NYNRIN FAM193A LMO7 DOCK7 CEP295 PRKDC MAP3K21 CDC25C | 5.28e-06 | 446 | 217 | 13 | 24255178 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.00e-06 | 208 | 217 | 9 | 33230847 | |
| Pubmed | 7.17e-06 | 43 | 217 | 5 | 12376548 | ||
| Pubmed | mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). | 8.23e-06 | 7 | 217 | 3 | 24870234 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ELAC2 TTLL12 GCN1 RNF213 NIBAN2 PAF1 RFC4 LMO7 ARID2 TLN1 PRKDC | 8.64e-06 | 332 | 217 | 11 | 32786267 |
| Pubmed | KDM3A MYCBP2 MPDZ BCOR KMT2C GCN1 PAF1 KMT2D LMO7 ARID2 TLN1 DOCK7 PRKDC SKA3 | 1.04e-05 | 549 | 217 | 14 | 38280479 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BCL7B DCAF16 TASOR2 TTLL12 SVIL MYPN RECQL4 MKI67 CLP1 GCN1 NXF1 KNL1 KPNA1 TLK2 NIBAN2 FAAP100 AKAP12 ARID2 TLN1 PRKDC CDC25C | 1.30e-05 | 1155 | 217 | 21 | 20360068 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GBF1 RPL13AP3 SPCS2 MPDZ DCAF16 PTEN ACAD11 NUP210 GCN1 KPNA1 PMPCB DUSP4 OBSL1 PTPRU FAAP100 RPAP1 PRKDC ASPRV1 CDC25C | 1.31e-05 | 974 | 217 | 19 | 28675297 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NRIP1 SPEG OBSCN TSC1 KMT2C PI3 NBEAL2 DHX37 NBEA VPS13D XIRP2 LMO7 ARID2 | 1.66e-05 | 497 | 217 | 13 | 36774506 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.85e-05 | 235 | 217 | 9 | 28378594 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.20e-05 | 184 | 217 | 8 | 32908313 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 TSC1 BCOR CDC7 TDRD3 NXF1 KNL1 TRAF7 OBSL1 PAF1 SLF2 LMO7 ARID2 CFAP44 | 2.23e-05 | 588 | 217 | 14 | 38580884 |
| Pubmed | 2.34e-05 | 242 | 217 | 9 | 34011540 | ||
| Pubmed | 2.68e-05 | 28 | 217 | 4 | 18617019 | ||
| Pubmed | NRIP1 MBD1 BCOR AHDC1 NYNRIN NXF1 WNK2 CSTPP1 KPNA1 BATF2 SLIT1 CHRD LTBP1 EPDR1 | 3.21e-05 | 608 | 217 | 14 | 16713569 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A GBF1 MYCBP2 BCOR SVIL MKI67 TLK2 PHRF1 NIBAN2 IQCN KMT2D RPAP1 LMO7 SLC7A5 PRKDC AKAP1 | 3.23e-05 | 774 | 217 | 16 | 15302935 |
| Pubmed | 3.52e-05 | 255 | 217 | 9 | 15324660 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.63e-05 | 256 | 217 | 9 | 33397691 | |
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 3.73e-05 | 60 | 217 | 5 | 12787561 | |
| Pubmed | MYCBP2 MPDZ TSC1 BCOR SLC12A5 TDRD3 CAMKV SVIL WNK2 KPNA1 TLK2 NYAP2 NBEA GRIN2D SIPA1 PAF1 AKAP12 DOCK7 | 3.87e-05 | 963 | 217 | 18 | 28671696 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 29728610 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 27362797 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 21051030 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 23220400 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 19052232 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 38876442 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 32945351 | ||
| Pubmed | Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. | 3.88e-05 | 2 | 217 | 2 | 22457330 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 19429706 | ||
| Pubmed | Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. | 3.88e-05 | 2 | 217 | 2 | 21479224 | |
| Pubmed | Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma. | 3.88e-05 | 2 | 217 | 2 | 26423666 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 25233425 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 14642363 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 3.88e-05 | 2 | 217 | 2 | 34156443 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 15185077 | ||
| Pubmed | Developmental patterns of Ki-67, Oct-4 and α-tubulin proteins expression in the human spinal cord. | 3.88e-05 | 2 | 217 | 2 | 24373696 | |
| Pubmed | hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells. | 3.88e-05 | 2 | 217 | 2 | 28122356 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 11912074 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 26655190 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 27280393 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 36869380 | ||
| Pubmed | Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium. | 3.88e-05 | 2 | 217 | 2 | 27143554 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 25213336 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 24574959 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 23882125 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 30540938 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 31924266 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 19211884 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 22389271 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 30503507 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 28967912 | ||
| Pubmed | Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology. | 3.88e-05 | 2 | 217 | 2 | 23664812 | |
| Pubmed | Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt. | 3.88e-05 | 2 | 217 | 2 | 29389670 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 36601880 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 28483418 | ||
| Pubmed | Differences in the large extracellular loop between the K(+)-Cl(-) cotransporters KCC2 and KCC4. | 3.88e-05 | 2 | 217 | 2 | 20516068 | |
| Pubmed | Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. | 3.88e-05 | 2 | 217 | 2 | 12106695 | |
| Pubmed | Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma. | 3.88e-05 | 2 | 217 | 2 | 34348664 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 17047059 | ||
| Pubmed | The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. | 3.88e-05 | 2 | 217 | 2 | 12023968 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 16288010 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 25346535 | ||
| Pubmed | 4.50e-05 | 102 | 217 | 6 | 11214970 | ||
| Pubmed | 4.75e-05 | 205 | 217 | 8 | 20436479 | ||
| Pubmed | 5.06e-05 | 12 | 217 | 3 | 22981605 | ||
| Pubmed | 5.45e-05 | 209 | 217 | 8 | 36779422 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 6.37e-05 | 67 | 217 | 5 | 34644545 | |
| Pubmed | 6.54e-05 | 13 | 217 | 3 | 19357198 | ||
| Pubmed | MPDZ NRP1 TTLL12 ACAD11 RECQL4 SIK2 NXF1 DHX37 OBSL1 POLR3A RPAP1 DOCK7 SLC12A7 PCDHGC3 | 6.57e-05 | 650 | 217 | 14 | 38777146 | |
| Pubmed | GBF1 PTEN NRP1 SVIL MYPN MKI67 ITGA8 SLF2 SLIT1 CABCOCO1 ACSL5 | 6.64e-05 | 415 | 217 | 11 | 16385451 | |
| Pubmed | KDM3A MYCBP2 BCL7B BCOR AHDC1 TTLL12 KMT2C MKI67 NXF1 KNL1 TLK2 UNCX CHMP5 PAF1 RFC4 KMT2D ARID2 TLN1 PRKDC | 6.99e-05 | 1103 | 217 | 19 | 34189442 | |
| Pubmed | 7.52e-05 | 162 | 217 | 7 | 25826454 | ||
| Pubmed | 8.28e-05 | 285 | 217 | 9 | 21423176 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 8.41e-05 | 71 | 217 | 5 | 28319113 | |
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 9.21e-05 | 38 | 217 | 4 | 19911011 | |
| Pubmed | 1.03e-04 | 15 | 217 | 3 | 18345009 | ||
| Pubmed | 1.11e-04 | 120 | 217 | 6 | 27320910 | ||
| Pubmed | 1.16e-04 | 3 | 217 | 2 | 27661110 | ||
| Pubmed | 1.16e-04 | 3 | 217 | 2 | 23136410 | ||
| Interaction | YWHAH interactions | NRIP1 GBF1 MYCBP2 SPEG PAK4 LRRK2 MPDZ TSC1 ARHGEF17 STARD9 SVIL RECQL4 SIK2 MAP3K9 WNK2 KIF26B CHMP5 KLF15 CRTC1 PLEKHG2 SIPA1 VPS13D IPO9 SLF2 LMO7 DOCK7 SKA3 MAP3K21 CDC25C AKAP1 | 2.06e-06 | 1102 | 214 | 30 | int:YWHAH |
| Interaction | YWHAZ interactions | SPARC GBF1 MYCBP2 SPEG RPL13AP3 PAK4 LRRK2 TSC1 BCOR SQOR CAMKV STARD9 NBEAL2 SVIL RECQL4 ARHGAP29 SIK2 MAP3K9 KATNIP PRR14L NXF1 WNK2 TLK2 KIF26B OBSL1 CRTC1 SIPA1 VPS13D IPO9 LMO7 DOCK7 MAP3K21 CDC25C | 3.74e-06 | 1319 | 214 | 33 | int:YWHAZ |
| Interaction | CSNK2A2 interactions | ACP2 BCL7B PTEN BCOR CDC7 NRP1 TTLL12 RECQL4 MKI67 ARHGAP29 PRR14L RMC1 GCN1 NXF1 PHRF1 PAF1 POLR3A RPAP1 POLR3E DOCK7 CDC25C PRDM16 | 8.72e-06 | 718 | 214 | 22 | int:CSNK2A2 |
| Interaction | YWHAG interactions | SPARC GBF1 MYCBP2 SPEG ACP2 MBD1 PAK4 LRRK2 MPDZ TSC1 ARHGEF17 TTLL12 STARD9 SVIL RECQL4 ARHGAP29 SIK2 MAP3K9 KIF26B CRTC1 PLEKHG2 SIPA1 VPS13D IPO9 LMO7 DOCK7 PRKDC SKA3 MAP3K21 CDC25C | 2.34e-05 | 1248 | 214 | 30 | int:YWHAG |
| Interaction | RNF123 interactions | OBSCN ARHGEF17 ELAC2 TTLL12 KMT2C TDRD3 ZBED4 RECQL4 MAP3K9 NXF1 ATRN MXRA5 KIF26B RNF213 NBEA THBS4 RPAP1 TLN1 CHRD CEP295 PRKDC CFAP44 MEGF10 | 2.39e-05 | 824 | 214 | 23 | int:RNF123 |
| Cytoband | 3q27 | 5.68e-06 | 25 | 217 | 4 | 3q27 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.04e-07 | 161 | 140 | 10 | 593 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.54e-04 | 4 | 140 | 2 | 628 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 8.16e-04 | 24 | 140 | 3 | 654 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.43e-03 | 29 | 140 | 3 | 396 | |
| GeneFamily | Fibronectin type III domain containing | 1.55e-03 | 160 | 140 | 6 | 555 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.62e-03 | 8 | 140 | 2 | 281 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.71e-03 | 66 | 140 | 4 | 722 | |
| GeneFamily | ESCRT-I | 2.07e-03 | 9 | 140 | 2 | 1116 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.07e-03 | 9 | 140 | 2 | 1230 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.28e-03 | 34 | 140 | 3 | 487 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.88e-03 | 181 | 140 | 6 | 694 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 3.13e-03 | 11 | 140 | 2 | 1025 | |
| GeneFamily | Immunoglobulin like domain containing | 3.94e-03 | 193 | 140 | 6 | 594 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.18e-03 | 42 | 140 | 3 | 602 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | GBF1 SPCS2 HMBS ZNF202 DCAF16 PTEN ARHGEF17 AHDC1 JAK1 RBMS3 NUP210 MKI67 CDON SZT2 C11orf54 POLR3A HIVEP3 VPS13D FAM193A DOCK7 CEP295 | 3.73e-06 | 807 | 216 | 21 | M14594 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | SPARC ATAD5 CDC7 JAK1 RECQL4 NUP210 MKI67 WDR90 KNL1 RFC4 AKAP12 DDIAS SPPL2A HASPIN PRR11 SKA3 CDC25C | 1.03e-05 | 597 | 216 | 17 | MM1309 |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | LPCAT1 CYP27B1 OBSCN BCOR ZBED4 CAMKV RECQL4 WDR90 CDON KPNA1 ADAMTS1 NMNAT3 POLR3E TLN1 CPXM1 MAP3K21 | 1.94e-05 | 563 | 216 | 16 | M15103 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | SPARC ATAD5 CDC7 JAK1 RECQL4 NUP210 MKI67 KNL1 RFC4 AKAP12 DDIAS SPPL2A HASPIN PRR11 SKA3 CDC25C | 2.67e-05 | 578 | 216 | 16 | M2368 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | SPARC PTEN ARHGEF17 PTGS2 SVEP1 JAK1 RBMS3 SVIL ARHGAP29 MXRA5 ADAMTS1 RBMS2 ITGA8 RNF213 PLEKHG2 AKAP12 TLN1 SLC12A7 PDZD2 | 3.55e-05 | 795 | 216 | 19 | M39050 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 3.68e-05 | 195 | 216 | 9 | M45684 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.83e-05 | 196 | 216 | 9 | M3008 | |
| Coexpression | GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | CYP27B1 DLEC1 BAHCC1 BATF2 FETUB AKAP12 CPXM1 ASPRV1 CABCOCO1 | 4.15e-05 | 198 | 216 | 9 | M6215 |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN | TICAM1 CYP27B1 BMP1 MFSD14B SEMA4D DUSP4 CHMP5 MAP3K13 ACSL5 | 4.31e-05 | 199 | 216 | 9 | M7119 |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 4.31e-05 | 199 | 216 | 9 | M7984 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 4.48e-05 | 200 | 216 | 9 | M387 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | NRIP1 TP53INP1 TSC1 ARHGAP29 MPL C11orf54 RNF213 NIBAN2 SLC12A7 | 4.48e-05 | 200 | 216 | 9 | M7518 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 6.50e-05 | 163 | 216 | 8 | M8235 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | ATAD5 ABHD3 SLC12A5 CDC7 STARD9 RECQL4 MKI67 GMPPB KNL1 RFC4 CPXM1 LTBP1 PRR11 SKA3 CDC25C | 7.94e-05 | 567 | 216 | 15 | M45692 |
| Coexpression | NABA_CORE_MATRISOME | SPARC SVEP1 COL24A1 HMCN2 MXRA5 THBS4 SLIT1 SLIT3 LTBP1 LTBP3 | 1.02e-04 | 275 | 216 | 10 | M5884 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | NRIP1 SPARC MPDZ PTGS2 JAK1 NBEAL2 MPL ADAMTS1 C11orf54 DUSP4 NBEA ZNF519 ARHGAP4 THBS4 DOCK7 LTBP1 LTBP3 | 1.09e-04 | 721 | 216 | 17 | M1999 |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 1.11e-04 | 176 | 216 | 8 | M7725 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | IL13RA1 SPARC ENPP2 MPDZ PTGS2 SVEP1 NRP1 BMP1 RBMS3 ARHGAP29 ADAMTS1 ITGA8 AKAP12 SLIT3 DOCK7 CPXM1 LTBP1 | 2.96e-06 | 445 | 214 | 17 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | IL13RA1 SPARC ENPP2 PTGS2 SVEP1 NRP1 BMP1 RBMS3 DTX4 ARHGAP29 ADAMTS1 SLIT3 CPXM1 LTBP1 LTBP3 EPDR1 | 2.19e-05 | 466 | 214 | 16 | GSM777050_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | ATAD5 CDC7 NRP1 TTLL12 CAMKV MKI67 KNL1 RFC4 ARHGAP4 DDIAS RORC PRR11 SKA3 CDC25C | 5.41e-05 | 397 | 214 | 14 | GSM791143_500 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | ATAD5 CDC7 NRP1 ZBED4 MKI67 KNL1 RFC4 AKAP12 DDIAS HASPIN RORC PRR11 SKA3 CDC25C | 5.56e-05 | 398 | 214 | 14 | GSM399397_500 |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGEF17 ACAD11 STARD9 NYNRIN KLF15 CRTC1 THBS4 IGHA1 SLIT3 CHRD LTBP1 PDZD2 | 3.22e-10 | 200 | 217 | 12 | 36de49593cf6ff1c9229fcceb150c1d68658a360 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | SPARC SVEP1 RBMS3 CDON MXRA5 ADAMTS1 ANGPTL1 AKAP12 SLIT3 CPXM1 LTBP1 | 3.07e-09 | 193 | 217 | 11 | 9ab47b360bee1d4f1092c2269e58acebe9584021 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-08 | 179 | 217 | 10 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-08 | 138 | 217 | 9 | d5342383c5e52b92c39d7afe76560501be3ea5cd | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-08 | 138 | 217 | 9 | e2659949944bdf39b23c7275e380a7a937e2726c | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | TP53INP1 SPCS2 COL24A1 RECQL4 NUP210 MKI67 KNL1 DDIAS IGHA1 SLC7A5 | 2.82e-08 | 186 | 217 | 10 | 66676d9395172de5707e204826a1c9f73b448cca |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-08 | 187 | 217 | 10 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-08 | 187 | 217 | 10 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-08 | 187 | 217 | 10 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPARC ATAD5 RECQL4 MKI67 KNL1 ANGPTL1 SLIT3 HASPIN PRR11 SKA3 | 4.20e-08 | 194 | 217 | 10 | 2360b5f995b360419de41612368cab9fb61781a1 |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPARC ATAD5 RECQL4 MKI67 KNL1 ANGPTL1 SLIT3 HASPIN PRR11 SKA3 | 4.20e-08 | 194 | 217 | 10 | cb39850e9577015b6b9834e98c36b412bae7d462 |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPARC ATAD5 RECQL4 MKI67 KNL1 ANGPTL1 SLIT3 HASPIN PRR11 SKA3 | 4.20e-08 | 194 | 217 | 10 | 408597c9aa302a44b112c1d612c21fbb0227a82a |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.20e-08 | 194 | 217 | 10 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPARC SVEP1 BMP1 RBMS3 ADAMTS1 AKAP12 SLIT3 CPXM1 LTBP1 LTBP3 | 4.41e-08 | 195 | 217 | 10 | 69a29d03e664b72f32d41876510c62345c3aed31 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | SVEP1 HMCN2 RBMS3 CDON ADAMTS1 ANGPTL1 AKAP12 SLIT3 CHRD LTBP1 | 4.41e-08 | 195 | 217 | 10 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPARC SVEP1 BMP1 RBMS3 ADAMTS1 AKAP12 SLIT3 CPXM1 LTBP1 LTBP3 | 4.41e-08 | 195 | 217 | 10 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPARC SVEP1 BMP1 RBMS3 ADAMTS1 AKAP12 SLIT3 CPXM1 LTBP1 LTBP3 | 4.41e-08 | 195 | 217 | 10 | 9cef6f18664518060af7c192310dddce6d70345a |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ARHGEF17 BMP1 RBMS3 STARD9 ARHGAP29 MXRA5 ADAMTS1 PLEKHG2 GRM8 SLC12A7 | 4.86e-08 | 197 | 217 | 10 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.34e-08 | 199 | 217 | 10 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | SPARC SVEP1 NRP1 RBMS3 MXRA5 ADAMTS1 ITGA8 ANGPTL1 AKAP12 SLIT3 | 5.34e-08 | 199 | 217 | 10 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | SPARC SVEP1 NRP1 RBMS3 MXRA5 ADAMTS1 ITGA8 ANGPTL1 AKAP12 SLIT3 | 5.34e-08 | 199 | 217 | 10 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | SPARC SVEP1 MXRA5 ADAMTS1 ITGA8 ANGPTL1 AKAP12 SLIT3 CPXM1 LTBP1 | 5.60e-08 | 200 | 217 | 10 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | SPARC SVEP1 RBMS3 MXRA5 ADAMTS1 ANGPTL1 AKAP12 SLIT3 CPXM1 LTBP1 | 5.60e-08 | 200 | 217 | 10 | 954fee8425673e76198be414f5f6c4e3597c1919 |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | SPARC SVEP1 MXRA5 ADAMTS1 ITGA8 ANGPTL1 AKAP12 SLIT3 CPXM1 LTBP1 | 5.60e-08 | 200 | 217 | 10 | bb605b373caf3f873dc1b87d712704568e0d6040 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-07 | 172 | 217 | 9 | 35c20de4db47dbf31c857d23c7a25cd7f95c085c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-07 | 174 | 217 | 9 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-07 | 130 | 217 | 8 | e5acaa9aaa22b10d11410e2c01647b31354c21ed | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-07 | 180 | 217 | 9 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-07 | 185 | 217 | 9 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.71e-07 | 193 | 217 | 9 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.71e-07 | 193 | 217 | 9 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.71e-07 | 193 | 217 | 9 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-07 | 194 | 217 | 9 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-07 | 194 | 217 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | SPARC SLC44A5 ARHGAP29 NIBAN2 VAT1L PTPRU AKAP12 LTBP1 EPDR1 | 4.92e-07 | 194 | 217 | 9 | f44394c8a6f86483063f2f5722f003a8a0a70254 |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.92e-07 | 194 | 217 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-07 | 194 | 217 | 9 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-07 | 194 | 217 | 9 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.13e-07 | 195 | 217 | 9 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-07 | 196 | 217 | 9 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.36e-07 | 196 | 217 | 9 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.59e-07 | 197 | 217 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.59e-07 | 197 | 217 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.83e-07 | 198 | 217 | 9 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-07 | 198 | 217 | 9 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.83e-07 | 198 | 217 | 9 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 5.83e-07 | 198 | 217 | 9 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.08e-07 | 199 | 217 | 9 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-07 | 199 | 217 | 9 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.08e-07 | 199 | 217 | 9 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 6.08e-07 | 199 | 217 | 9 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.08e-07 | 199 | 217 | 9 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-07 | 199 | 217 | 9 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 6.08e-07 | 199 | 217 | 9 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.08e-07 | 199 | 217 | 9 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 6.08e-07 | 199 | 217 | 9 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.08e-07 | 199 | 217 | 9 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.08e-07 | 199 | 217 | 9 | 4f02e03c118744fba0dfc5e3ed6dea4041f3d089 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.08e-07 | 199 | 217 | 9 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.08e-07 | 199 | 217 | 9 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-07 | 200 | 217 | 9 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.34e-07 | 200 | 217 | 9 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | 356C-Fibroblasts|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-07 | 200 | 217 | 9 | 9c95329f0b26ff378de803030d4c28517b3adc85 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.34e-07 | 200 | 217 | 9 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 6.34e-07 | 200 | 217 | 9 | ee3d06865a6300e1279edf6664320b71647f5efb | |
| ToppCell | -Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-06 | 164 | 217 | 8 | 2d65f025f921a5327bfd8d260815baaed00ef3fa | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.61e-06 | 166 | 217 | 8 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.61e-06 | 166 | 217 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.69e-06 | 167 | 217 | 8 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 168 | 217 | 8 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 169 | 217 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 173 | 217 | 8 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 2.29e-06 | 174 | 217 | 8 | 029394e107bf7ad58056d2216070aa2e964fff12 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 175 | 217 | 8 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 175 | 217 | 8 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 177 | 217 | 8 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-06 | 179 | 217 | 8 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-06 | 179 | 217 | 8 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-06 | 180 | 217 | 8 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 180 | 217 | 8 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-06 | 181 | 217 | 8 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-06 | 181 | 217 | 8 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.08e-06 | 181 | 217 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 182 | 217 | 8 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 182 | 217 | 8 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 182 | 217 | 8 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 3.34e-06 | 183 | 217 | 8 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 184 | 217 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Stromal-SMC|World / Disease state, Lineage and Cell class | 3.47e-06 | 184 | 217 | 8 | 88b1a4c9a96a99fc3a39f7a2c3d0838739606f3e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 184 | 217 | 8 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.76e-06 | 186 | 217 | 8 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 186 | 217 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 186 | 217 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.92e-06 | 187 | 217 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 3.92e-06 | 187 | 217 | 8 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-06 | 188 | 217 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 188 | 217 | 8 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| Drug | pyrachlostrobin | SPARC TP53INP1 LRRK2 SQOR SVEP1 SVIL MKI67 CDON KNL1 TCAF2 ADAMTS1 RBMS2 ITGA8 PLEKHG2 AKAP12 DDIAS SLF2 TLN1 MOB3B LTBP1 LTBP3 SLC12A7 PRDM16 MEGF10 | 8.80e-07 | 811 | 216 | 24 | ctd:C513428 |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | AGBL5 TDRD3 NUP210 SIK2 BAHCC1 SEMA4D ARHGAP4 VPS13D THBS4 RPAP1 TLN1 | 2.90e-06 | 196 | 216 | 11 | 1156_DN |
| Disease | pulse pressure measurement | NRIP1 TP53INP1 ENPP2 MBD1 UBAP1 PTEN AHDC1 SVEP1 MYPN DLEC1 TRAF7 MXRA5 NYAP2 RNF213 NBEA SIPA1 PKD1L3 HIVEP3 FAM193A SLIT1 SLIT3 CPXM1 LTBP1 LTBP3 MBD5 CABCOCO1 PRDM16 | 2.15e-06 | 1392 | 209 | 27 | EFO_0005763 |
| Disease | in situ carcinoma (is_marker_for) | 1.33e-05 | 21 | 209 | 4 | DOID:8719 (is_marker_for) | |
| Disease | platelet crit | NRIP1 SLC38A9 LRRK2 SUSD3 PTEN CDC7 TTLL12 JAK1 SVIL ARHGAP29 MPL NYAP2 ZNF407 POU5F1 NIBAN2 TLN1 CHRD SLC7A5 SLC12A7 PRDM16 | 1.59e-05 | 952 | 209 | 20 | EFO_0007985 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 4.99e-05 | 2 | 209 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | response to docetaxel trihydrate | 4.99e-05 | 2 | 209 | 2 | GO_1902519 | |
| Disease | intraocular pressure measurement | COL24A1 DLEC1 CSTPP1 MXRA5 HIVEP3 THBS4 LMO7 CPXM1 LTBP1 LTBP3 CDC25C PRDM16 | 3.00e-04 | 509 | 209 | 12 | EFO_0004695 |
| Disease | citrulline measurement | 3.65e-04 | 20 | 209 | 3 | EFO_0009777 | |
| Disease | treatment resistant depression, response to antidepressant | 4.24e-04 | 21 | 209 | 3 | EFO_0009854, GO_0036276 | |
| Disease | platelet measurement | 4.40e-04 | 315 | 209 | 9 | EFO_0005036 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.83e-04 | 139 | 209 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | arecaidine measurement | 4.92e-04 | 5 | 209 | 2 | EFO_0801112 | |
| Disease | Intrahepatic Cholangiocarcinoma | 6.35e-04 | 24 | 209 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 6.35e-04 | 24 | 209 | 3 | C3805278 | |
| Disease | pallidum volume change measurement, age at assessment | 7.18e-04 | 25 | 209 | 3 | EFO_0008007, EFO_0021494 | |
| Disease | brain disease (implicated_via_orthology) | 7.35e-04 | 6 | 209 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | insulin measurement, glucose tolerance test | 7.35e-04 | 6 | 209 | 2 | EFO_0004307, EFO_0004467 | |
| Disease | Adenoid Cystic Carcinoma | 7.42e-04 | 100 | 209 | 5 | C0010606 | |
| Disease | Cholangiocarcinoma | 8.08e-04 | 26 | 209 | 3 | C0206698 | |
| Disease | Hallux valgus | 8.74e-04 | 60 | 209 | 4 | HP_0001822 | |
| Disease | Sezary Syndrome | 9.04e-04 | 27 | 209 | 3 | C0036920 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 9.15e-04 | 157 | 209 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | mean arterial pressure | SVEP1 BAHCC1 NYAP2 SZT2 DUSP4 RNF213 SIPA1 GRM7 HIVEP3 CABCOCO1 PRDM16 | 9.22e-04 | 499 | 209 | 11 | EFO_0006340 |
| Disease | neuropilin-1 measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0020603 | |
| Disease | complement C1r subcomponent measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0008090 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.05e-03 | 63 | 209 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | response to bronchodilator, FEV/FEC ratio | SPARC ENPP2 FANCD2OS PRSS46P COL24A1 LRFN2 RBMS3 NBEAL2 NUP210 DLEC1 VAV2 GRM8 FAM193A PRDM16 | 1.20e-03 | 766 | 209 | 14 | EFO_0004713, GO_0097366 |
| Disease | D dimer measurement | 1.24e-03 | 30 | 209 | 3 | EFO_0004507 | |
| Disease | bipolar II disorder | 1.36e-03 | 8 | 209 | 2 | EFO_0009964 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 1.36e-03 | 8 | 209 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 1.36e-03 | 8 | 209 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | diastolic blood pressure, self reported educational attainment | 1.36e-03 | 8 | 209 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | Polycythemia Vera | 1.36e-03 | 8 | 209 | 2 | C0032463 | |
| Disease | Leukemia, Myelocytic, Acute | 1.51e-03 | 173 | 209 | 6 | C0023467 | |
| Disease | Colorectal Carcinoma | SPARC OBSCN PTEN PTGS2 SLC12A5 KMT2C MKI67 PTPRU AKAP12 HIVEP3 RPAP1 LMO7 ACSL5 | 1.59e-03 | 702 | 209 | 13 | C0009402 |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.64e-03 | 71 | 209 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | response to topoisomerase inhibitor, response to antineoplastic agent | 1.74e-03 | 9 | 209 | 2 | GO_0072758, GO_0097327 | |
| Disease | X-18921 measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0800796 | |
| Disease | cis-4-decenoate (10:1n6) measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0800318 | |
| Disease | Malignant neoplasm of breast | KDM3A NRIP1 TICAM1 OBSCN SUSD3 PTEN PTGS2 BMP1 MKI67 ARHGAP29 DLEC1 ADAMTS1 GRIN2D RFC4 AKAP12 KMT2D MAP3K13 | 1.75e-03 | 1074 | 209 | 17 | C0006142 |
| Disease | posterior thigh muscle fat infiltration measurement | 1.94e-03 | 35 | 209 | 3 | EFO_0020934 | |
| Disease | brain measurement, neuroimaging measurement | ENPP2 RPL13AP3 ELAC2 NRP1 ACAD11 WNK2 BAHCC1 MPL SEMA4D KIF26B PRDM16 | 1.99e-03 | 550 | 209 | 11 | EFO_0004346, EFO_0004464 |
| Disease | creatinine measurement | SPEG OBSCN SQOR PTGS2 SVIL MYPN DLEC1 NYAP2 UNCX KIF26B PKD1L3 SPPL2A SLF2 DOCK7 MBD5 MEGF10 | 2.04e-03 | 995 | 209 | 16 | EFO_0004518 |
| Disease | Parkinson disease | 2.15e-03 | 321 | 209 | 8 | MONDO_0005180 | |
| Disease | leptin measurement, sex interaction measurement | 2.16e-03 | 10 | 209 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | coronary artery disease | AHDC1 SVEP1 NRP1 BMP1 LRFN2 ACAD11 NUP210 SIK2 DLEC1 WNK2 NYAP2 RNF213 PTPRU SIPA1 PKD1L3 AKAP12 LINGO4 PRDM16 | 2.20e-03 | 1194 | 209 | 18 | EFO_0001645 |
| Disease | body surface area | SLC38A9 ENPP2 FANCD2OS COL24A1 LRFN2 DLEC1 UNCX SLF2 SLIT1 SLIT3 LTBP1 LTBP3 | 2.24e-03 | 643 | 209 | 12 | EFO_0022196 |
| Disease | Astigmatism | 2.30e-03 | 129 | 209 | 5 | HP_0000483 | |
| Disease | sexual dimorphism measurement | ATAD5 SLC38A9 DCAF16 CAMKV RBMS3 NYNRIN RMC1 GCN1 CSTPP1 NYAP2 SIPA1 PKD1L3 ZNF557 SLIT1 SLIT3 LTBP1 LTBP3 | 2.38e-03 | 1106 | 209 | 17 | EFO_0021796 |
| Disease | hematocrit | NRIP1 ACAD11 RBMS3 VAV2 BAHCC1 SEMA4D NYAP2 UNCX RBMS2 KLF15 CRTC1 SPPL2A ARID2 LINGO4 SLC7A5 PRDM16 | 2.39e-03 | 1011 | 209 | 16 | EFO_0004348 |
| Disease | blood molybdenum measurement | 2.46e-03 | 38 | 209 | 3 | EFO_0007582 | |
| Disease | Barrett's esophagus (is_marker_for) | 2.63e-03 | 11 | 209 | 2 | DOID:9206 (is_marker_for) | |
| Disease | waist-hip ratio | MYCBP2 SLC38A9 ATXN7L1 HMBS NRP1 COL24A1 LRFN2 DLEC1 RMC1 CDON KNL1 NYAP2 ZNF407 CRTC1 IQCN SIPA1 LTBP3 PRDM16 | 2.91e-03 | 1226 | 209 | 18 | EFO_0004343 |
| Disease | platelet component distribution width | NRIP1 TP53INP1 LRRK2 SVEP1 NYNRIN SVIL DLEC1 VAV2 NYAP2 TLN1 DOCK7 SLC12A7 PRDM16 | 2.98e-03 | 755 | 209 | 13 | EFO_0007984 |
| Disease | Dental enamel hypoplasia | 3.14e-03 | 12 | 209 | 2 | EFO_1001304 | |
| Disease | Bladder Neoplasm | 3.27e-03 | 140 | 209 | 5 | C0005695 | |
| Disease | ascending aortic diameter | 3.27e-03 | 140 | 209 | 5 | EFO_0021787 | |
| Disease | Malignant neoplasm of urinary bladder | 3.37e-03 | 141 | 209 | 5 | C0005684 | |
| Disease | stomach cancer (is_marker_for) | 3.48e-03 | 142 | 209 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Liver carcinoma | 3.48e-03 | 507 | 209 | 10 | C2239176 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Thyroid carcinoma | 3.75e-03 | 44 | 209 | 3 | C0549473 | |
| Disease | chronic obstructive pulmonary disease | SPEG MBD1 ARHGEF17 RBMS3 SVIL MYPN DLEC1 ITGA8 CRTC1 SPPL2A RPAP1 PDZD2 | 3.85e-03 | 688 | 209 | 12 | EFO_0000341 |
| Disease | body weight | IL13RA1 ATAD5 MBD1 SQOR LRFN2 RBMS3 RMC1 UNCX CRTC1 VAT1L GRM7 IPO9 POLR3E SLIT1 SLIT3 LTBP1 LTBP3 PDZD2 | 3.91e-03 | 1261 | 209 | 18 | EFO_0004338 |
| Disease | Malignant neoplasm of kidney | 3.99e-03 | 45 | 209 | 3 | C0740457 | |
| Disease | Gastric Adenocarcinoma | 3.99e-03 | 45 | 209 | 3 | C0278701 | |
| Disease | Calcium channel blocker use measurement | 4.23e-03 | 213 | 209 | 6 | EFO_0009930 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma Of Esophagus | 4.30e-03 | 14 | 209 | 2 | C0279628 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | albuminuria | 4.54e-03 | 94 | 209 | 4 | EFO_0004285 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.64e-03 | 152 | 209 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | MBD1 PTEN PTGS2 ELAC2 NRP1 JAK1 KMT2C KLF15 KMT2D ARID2 PRKDC | 4.69e-03 | 616 | 209 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | MBD1 PTEN PTGS2 ELAC2 NRP1 JAK1 KMT2C KLF15 KMT2D ARID2 PRKDC | 4.69e-03 | 616 | 209 | 11 | C0376358 |
| Disease | Squamous cell carcinoma of esophagus | 4.71e-03 | 95 | 209 | 4 | C0279626 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 4.93e-03 | 15 | 209 | 2 | EFO_0008223 | |
| Disease | caffeine measurement | 4.93e-03 | 15 | 209 | 2 | EFO_0021177 | |
| Disease | Hepatitis | 4.93e-03 | 15 | 209 | 2 | C0019158 | |
| Disease | employment status | 4.93e-03 | 15 | 209 | 2 | EFO_0005241 | |
| Disease | mean arterial pressure, alcohol drinking | 5.26e-03 | 98 | 209 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 5.37e-03 | 50 | 209 | 3 | EFO_0010732 | |
| Disease | corpus callosum volume measurement | 5.65e-03 | 100 | 209 | 4 | EFO_0010299 | |
| Disease | serum gamma-glutamyl transferase measurement | TP53INP1 BCL7B RBMS3 NBEAL2 SVIL GCN1 BAHCC1 ATRN NYAP2 KLF15 FAAP100 SPPL2A TLN1 RORC | 5.83e-03 | 914 | 209 | 14 | EFO_0004532 |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.84e-03 | 301 | 209 | 7 | DOID:684 (is_marker_for) | |
| Disease | Generalized seizures | 5.85e-03 | 101 | 209 | 4 | C0234533 | |
| Disease | Clonic Seizures | 5.85e-03 | 101 | 209 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 5.85e-03 | 101 | 209 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 5.85e-03 | 101 | 209 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 5.85e-03 | 101 | 209 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 5.85e-03 | 101 | 209 | 4 | C0751123 | |
| Disease | Complex partial seizures | 5.85e-03 | 101 | 209 | 4 | C0149958 | |
| Disease | Single Seizure | 5.85e-03 | 101 | 209 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 5.85e-03 | 101 | 209 | 4 | C3495874 | |
| Disease | Visual seizure | 5.85e-03 | 101 | 209 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 5.85e-03 | 101 | 209 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 5.85e-03 | 101 | 209 | 4 | C0422855 | |
| Disease | Gustatory seizure | 5.85e-03 | 101 | 209 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 5.85e-03 | 101 | 209 | 4 | C0422850 | |
| Disease | Olfactory seizure | 5.85e-03 | 101 | 209 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 5.85e-03 | 101 | 209 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 5.85e-03 | 101 | 209 | 4 | C4505436 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVLCKSGLGFPPQLF | 96 | Q6ZRU5 | |
| LPTAATAICALPGPL | 366 | Q66K41 | |
| LGQPEVCFVPKSPPL | 866 | Q8NDL9 | |
| PLPVDTIPETKNFCG | 1516 | Q96QE3 | |
| VPVFIGCPPGKRLAF | 876 | Q6ZRH7 | |
| LGIKDPSVFTPPSTC | 196 | Q9UM22 | |
| LLPPDFKIQCTEPSP | 2031 | Q9P281 | |
| KSIPLECPLSSPKGV | 141 | Q92667 | |
| VVKSACGPFPNPLEE | 101 | Q8IVU9 | |
| AKEVSSLEGSPPPCL | 1386 | Q02952 | |
| GPGAPPFLLILVCTA | 66 | O96024 | |
| PPPGIVEIDSEKFAC | 511 | Q68CP9 | |
| EGPFPCNFVLTKTPK | 691 | Q96SM3 | |
| SPSPRLKSVGIPVLC | 326 | Q8WU67 | |
| IPPVTFINEGPFKDC | 266 | O95841 | |
| KRPTELCPSPQFIVG | 76 | A6NHC0 | |
| TCSPTLGFKEELRPP | 1401 | Q5TGY3 | |
| PDCKTIRIIYSIPPG | 496 | Q9Y2E6 | |
| PVLGRFCGSKKPEPV | 816 | P13497 | |
| GAPPLKRFCVDQPTV | 181 | Q9BQE9 | |
| KTQEDPKPFCVGSAP | 916 | Q6W2J9 | |
| EIFIPSTPSPILCGF | 741 | Q96MT7 | |
| GFVDTRKSFCPAPLP | 711 | P78312 | |
| LASCGVPPFQKPLTS | 116 | Q9NXF7 | |
| TVFPAKGSRDKPCVP | 181 | Q9ULK2 | |
| SIGFPVPKPILYCSD | 96 | Q709F0 | |
| VPAPSDPLLCKFADG | 206 | Q15434 | |
| IPAPSEPLLCKFADG | 211 | Q6XE24 | |
| FVLQPKVVDGTPCSP | 671 | Q9UHI8 | |
| GPVKAETPKAPFQIC | 316 | Q9H0B3 | |
| CGPFIKLSDPGIPIT | 731 | P23458 | |
| SGSAPILKCPTQFPL | 146 | Q96TA1 | |
| NEEIFPTCVGVPFPK | 131 | Q86TA1 | |
| FPPTKLELCATRPEG | 1431 | Q96PE2 | |
| KAPPPSLTDCIGTVD | 11 | Q9NZZ3 | |
| PGPSTPSFLAELFCK | 41 | O15528 | |
| PPVLIPKSSECGYVE | 1036 | Q96KG7 | |
| PAPVVEPLKCAPKTF | 241 | O75147 | |
| AVEPAVVKFVCAPPS | 736 | Q8TEM1 | |
| EASKVVLLPSCPGAP | 36 | O75636 | |
| IPALPPCKFTGSEIR | 271 | O75439 | |
| CLITFKPGAFIPGAP | 216 | Q8NF37 | |
| AQLPIKTCTPAPGTV | 3356 | Q8NEZ4 | |
| ERITPFTKGKCPPTV | 396 | Q3ZCV2 | |
| PDCPLGKSFEELPVS | 646 | Q8NI17 | |
| TLDCEAKGSPPPLVT | 1091 | Q8NDA2 | |
| LLPCEASGSPKPLVV | 3776 | Q8NDA2 | |
| LCVSPPEGFLIRKGP | 1336 | O60303 | |
| TVPKPIALEPCFGNK | 1351 | O75882 | |
| GVNEVCSPTKPAAPF | 21 | Q2KJY2 | |
| PLTLSTPKPLVDFCN | 16 | Q9Y5P6 | |
| PCFSSLPEHLGSVPK | 961 | Q9H252 | |
| LPFPKEKARTAECPG | 356 | Q9UGM5 | |
| LTSPVLVPGCPSKAV | 516 | Q9UIS9 | |
| PPPETGESVCLQLKS | 116 | Q16342 | |
| KCPLPGTAAFKEICP | 716 | Q14766 | |
| AFDVEAPTTLPPCKG | 361 | Q9UBU9 | |
| CVLESKPPLATSGPL | 1956 | O15018 | |
| PFLGVACAVAPTEAP | 96 | A0A1B0GUS0 | |
| VKCCLPFSEKGPPSV | 971 | Q8IXT1 | |
| CPPEILSETLPGSVK | 56 | Q9UHL3 | |
| SCIPSVLKPVEPSLG | 406 | Q9P1Y6 | |
| FPTCPVPEEAAKLVA | 161 | Q01650 | |
| PISFTPGPCSEADLK | 656 | Q8WWI1 | |
| APIFPCLLGEPKIQA | 136 | P12525 | |
| GPSVVLDPTVKCPTL | 1071 | Q5S007 | |
| VKTPVSPTFPEHLGC | 1006 | P48552 | |
| CPFTSFSVPDPELIK | 561 | P35354 | |
| LPPGFKRFSCLSLPE | 96 | Q8NG31 | |
| KGPVSTKPGSCPIIL | 66 | P19957 | |
| SCLPPLVPAIKEDAG | 1361 | Q92616 | |
| FTPYVGPIIPCILKA | 1771 | Q92616 | |
| FPTCPVPEEAAKLVA | 161 | Q9GIP4 | |
| LTAGKATKIPCESPP | 2696 | P46013 | |
| FAKASVPCPPKGLLC | 306 | Q9P242 | |
| LVTCEVPPGLPFSLT | 386 | Q9UN70 | |
| ASLDCLKVFDGIPPP | 11 | Q6NVV1 | |
| GKPAAPHFLPVLCSV | 186 | Q0VG06 | |
| VKCANGDPPIFTKPD | 131 | O00222 | |
| PTPEKDPVGTCYVAI | 161 | P53708 | |
| PCVSGGLPKPANITF | 31 | Q9UHF4 | |
| SILVEKCISPPEGDP | 111 | P78552 | |
| VVDKSPLPLGFSPVC | 76 | Q96EY5 | |
| IPGPPFLFGACSVLL | 426 | Q96MC6 | |
| VCPDVPRTPVGKFLG | 41 | P30307 | |
| SPEPCTVTPGAVKLE | 111 | Q01860 | |
| KASTPPDAGPIVIHC | 1071 | Q92729 | |
| CKEAPLVPSSPFLGQ | 7066 | Q5VST9 | |
| HLPVPSTCPDGFKIL | 371 | O43283 | |
| GKFCGKIAPPPVVSS | 101 | O14786 | |
| ITEDRLLKFPLGPCP | 146 | P11117 | |
| SPFLESGVSPKLPCH | 61 | Q96PS1 | |
| CNSLPDIPFDPKFIT | 36 | Q8N7H5 | |
| VVDQGCFPKPLLSPE | 901 | Q52LW3 | |
| GSKAPVPCFGPVFTE | 306 | Q5T8I9 | |
| PGPVVFPGKSVILRC | 881 | Q8N6C5 | |
| VPQALTGLPKECLPT | 406 | Q9Y4C1 | |
| LIKEPCGTPEYLAPE | 176 | Q8NCB2 | |
| KTGQFCLPVSLEKPP | 681 | Q96N67 | |
| SCPPPALVKEALSNV | 216 | Q9H6J7 | |
| TPGFRAPEVLTKCPN | 376 | O00311 | |
| SRPKSCEVPGINIFP | 211 | Q6UUV9 | |
| CPLPSLSLGPAVVAE | 151 | Q8N1L9 | |
| ALILPPVPEGCAEKT | 1251 | Q4KMG0 | |
| PKVFPLSLCSTQPDG | 6 | P01876 | |
| APTKAPDVFPIISGC | 1 | P01880 | |
| PLPTPALICILTFGA | 11 | Q9ULC5 | |
| KPVPPSPEDLSVICF | 246 | Q9ULC5 | |
| PTQKPLGRCFQDTLP | 271 | Q9NS15 | |
| GPVPFSHCLPTEKLQ | 471 | Q8TF76 | |
| TPAKFNTCPLPGALL | 221 | Q9ULV5 | |
| LGPFCGEKAPEPIST | 256 | P48740 | |
| CPLILPKVFNFDPGA | 66 | Q9P267 | |
| LEFLCSLPGPTGKPA | 821 | Q96P70 | |
| LFTLLECIGSGVKPP | 1266 | Q92538 | |
| LPVDENFSSPKCPVG | 6 | Q9UIH9 | |
| CTNGEPPVFVKPEKV | 136 | Q14831 | |
| VPVSFKPAVCLPVSC | 46 | P59991 | |
| DDCPTAIFPSKPFLQ | 166 | Q8NCS7 | |
| PTVLPPGFTIGAICK | 101 | P08397 | |
| IPLPFAEAKPKSTCE | 1656 | Q9C0D2 | |
| CADTPVFLAKPPIGF | 366 | Q9Y238 | |
| FKPPPEGTRLCVVAT | 606 | Q8IY37 | |
| EFCSKTKALAAIPPP | 156 | Q13115 | |
| PVCLPNIKFKPSIGS | 146 | E5RG02 | |
| IKSAFDPPDIPVCLL | 296 | Q9Y666 | |
| VFASFPSPPLSKDCI | 411 | Q8NBW4 | |
| VLAAGCKQILVPFPP | 611 | Q9NVU0 | |
| ECPAGFVRPPLIIFS | 156 | Q13822 | |
| LALPIPSTCPEPFAK | 366 | P80192 | |
| VIPGPPFLFGACIVL | 426 | Q5SR56 | |
| DILPPGHFTCKPALI | 401 | Q6UY18 | |
| SPFPLGALVPVTAVC | 31 | O43193 | |
| PPFPALVPKSCLVAE | 1946 | Q5THK1 | |
| FEFPQPLPVCGDIKV | 241 | P60484 | |
| KLLFQPPVSALGVCP | 331 | Q9P2P1 | |
| KPLVDPACITSIQPG | 51 | O96013 | |
| PACITSIQPGAPKTI | 56 | O96013 | |
| GVIKSAFDPPNFPIC | 296 | Q9H2X9 | |
| CKLTPADVEFIQPPG | 2201 | Q5T011 | |
| SDGKPCPPFKIVILD | 136 | P35249 | |
| IFTFPNTPVKCAGAP | 191 | Q9Y6N5 | |
| SGSPVCKLVPPHETF | 86 | Q96L08 | |
| PPCLPTVAFLSGLVG | 216 | Q8N808 | |
| KPAGPVTAVPCDDKI | 511 | Q9H7E2 | |
| PTAITPVASPICGKT | 1226 | O95425 | |
| SILPQTLKAGCFPVP | 391 | A6NFQ2 | |
| CFRPSLKLTGPKEAP | 226 | Q5T9Z0 | |
| LTLPIPSTCPEPFAK | 361 | Q5TCX8 | |
| SEVPDFLGAPKACRP | 196 | O94761 | |
| LSNLCRGKSPPPEFA | 236 | P52294 | |
| PPEFAKVSPCLNVLS | 246 | P52294 | |
| LCTLGPNETAPFKPE | 821 | Q6ZNJ1 | |
| PGCSAAAIALPPIAK | 236 | Q8NFP9 | |
| GPSAECPFDLTTKPK | 766 | Q9HAZ2 | |
| SLGFKVPPTVCPFHS | 346 | Q7Z443 | |
| VFPCPSEPALSKNEL | 931 | O14802 | |
| VCGALPFDGPTLPIL | 211 | Q9H0K1 | |
| VFQEPGSKPFCPTTI | 436 | Q96FS4 | |
| APKVCVTVLPPDESG | 751 | Q96FS4 | |
| PASISEPPPFKCLLI | 1091 | O75592 | |
| ECLEKFFSTGPARPP | 46 | P60153 | |
| TPTKSPPAALEVVPC | 551 | Q8IX21 | |
| PAPTGTSCEPKIVIN | 701 | Q92854 | |
| SCPVLEAIGAPKPAY | 1496 | Q9P2P6 | |
| VIKGSPCEIPFTPVN | 721 | Q4LDE5 | |
| CKIVLCTPPPLISFG | 2376 | Q4LDE5 | |
| LAVCFGPTLLPVPAG | 656 | P98171 | |
| PECFVVGKEPPKISN | 646 | Q86UE8 | |
| APSCLPKAGQVIPTL | 36 | Q53RT3 | |
| IYKVGAPTIPDSCLP | 326 | Q92989 | |
| PVVPPFGLIKCAVCT | 801 | Q9H2X0 | |
| KGLVDTPCFQRTPTP | 126 | A8K5M9 | |
| PLVCLPVFVSRDPGF | 246 | Q9H0W9 | |
| CLPPVSVTKLEFGVG | 1586 | Q17RW2 | |
| PPGFAGPRCEKLITV | 1146 | O75094 | |
| KLSKGAIPCPAATPV | 3016 | A4UGR9 | |
| VPTFCTPGLKIPSTK | 286 | Q8IX90 | |
| LPDGKSTDFLPVDCP | 601 | Q63HN8 | |
| CGPLKFQSPTPSTVV | 261 | P35443 | |
| DTPKQAFTPIDLPCG | 546 | Q92574 | |
| LETSIFTPSPCKIPP | 576 | Q92574 | |
| IEKSCSPPEAVLLGP | 236 | Q96KV7 | |
| PAKVGLPIGFSLPDC | 31 | Q9NZ09 | |
| KKPQFLSAAPTEPCI | 126 | Q8TB69 | |
| LCTPPDPGAAFVVVE | 296 | Q9BQ52 | |
| LPEASACPPGLLKAS | 166 | P51449 | |
| AIFASDPATCPIIPG | 1611 | O75970 | |
| ARFDCKISGTPPPVV | 1081 | Q15772 | |
| EEILTLFCGAPPVTP | 511 | Q9UMS5 | |
| LFCGAPPVTPIIVLS | 516 | Q9UMS5 | |
| GPAAVTSQSPVPCKL | 321 | Q96DM3 | |
| LPVCLPDPSVIFETG | 141 | Q9BQR3 | |
| ELAVFCSPEPPAKTS | 2156 | Q9Y490 | |
| PFPESKPVLALCVIS | 106 | Q15005 | |
| IGPCKYIPPCLDSEL | 146 | P09486 | |
| GSPDCVIPFLPLESS | 481 | Q8IUC6 | |
| PPCFTAGGLTTIKVE | 101 | Q96A56 | |
| PLCNLSDIPPVGIKS | 71 | Q8TCT8 | |
| PKFEEPPSKGTTVCG | 1356 | Q5T1R4 | |
| PIFEVDPRGCPFTIK | 201 | Q6Q0C0 | |
| FVDSVGLPAPPSIIK | 126 | P40238 | |
| PKTPLVPGFECSGIV | 96 | Q9HCJ6 | |
| VPALEAPPSLVSLGC | 861 | Q9BWH6 | |
| TELFQVACAKPPPLG | 556 | Q14166 | |
| LCPRQDGPSPKFQLT | 381 | Q6ZN44 | |
| CSKPVVLPKGPESES | 491 | P78527 | |
| VASLGFPVPKPELIS | 51 | Q9BRH9 | |
| DKTICAVAPVPALPG | 521 | Q6P2C0 | |
| EDLISFLCGKVPPPR | 141 | Q14CZ0 | |
| VPTTPALPKEICSDF | 1016 | Q9H7P9 | |
| SGFDLIPPAEKCPSE | 241 | Q5VWN6 | |
| SKPEIQLSPSCPLIF | 106 | P10072 | |
| SPFPPKEISVSCTIG | 166 | Q9C0G0 | |
| LEVIPPCKFTSPADL | 566 | P52735 | |
| LVVGLAPCTPAPEAA | 1486 | Q9Y3S1 | |
| CPDVENPFKAKGLTP | 106 | Q8N988 | |
| TTPAKKFECQGPPTL | 906 | O75093 | |
| CGIVVSLSFPIPRPD | 271 | O95125 | |
| CVLITPGDSKAVLPP | 161 | Q96HE9 | |
| PAKLPCLSPEALLVG | 276 | A6NL46 | |
| FAPGLPCAPRTLIGK | 361 | A6NJT0 | |
| FLGCPPSIVPSEKLF | 1121 | O75132 | |
| ENFPLCKELLIPPGT | 3231 | Q5THJ4 | |
| PCQFTIATPKVEPAP | 3131 | O14686 | |
| TLCPSKGLLFVPPDI | 36 | Q9ULH4 | |
| TVFPCEATGKPKPFV | 1871 | Q9NR99 | |
| PVTFTCKIVGIPVPK | 961 | Q86TC9 | |
| PFVIVEPADPISGTC | 441 | O15399 | |
| FSTPAAVPELKLLCG | 121 | Q96T66 |